Balfour Beatty PLC
03 July 2007
3 July 2007
BALFOUR BEATTY REACHES FINANCIAL CLOSE FOR THE
£311 MILLION PPP PINDERFIELDS AND PONTEFRACT HOSPITALS DEVELOPMENT PROJECT
==========================================================================
Balfour Beatty, the international engineering, construction, services and
investment group, announces that its PPP healthcare vehicle, Consort Healthcare,
reached financial close for the Mid Yorkshire Hospitals NHS Trust's Pinderfields
and Pontefract Hospitals Development PPP Project on Thursday 28 June. The
project has a capital value of approximately £311 million.
The 35-year concession is central to the reconfiguration of health services in
the area. It will deliver a new acute inpatient hospital in Wakefield on the
existing Pinderfields Hospital site and a new Diagnostic and Treatment Centre in
Pontefract.
Balfour Beatty will invest some £15 million of equity in the project. Balfour
Beatty Group companies will be responsible for all of the construction, building
services and physical facilities management.
Commenting on the financial close of the project, Balfour Beatty Chief
Executive, Ian Tyler, said:
'We are delighted to be in a position to deliver the largest PPP hospital
development in Yorkshire. When complete, the project will enable the
transformation of hospital services across Wakefield and Pontefract and the
optimisation of services at Dewsbury District Hospital to achieve the Trust's
ambitions of high-quality patient care. Balfour Beatty is bringing to the task
many decades of experience in working as a key contractor in the healthcare
sector and its expertise in planning, constructing and operating other large PPP
hospitals.'
Sir Hugh Sykes, Chairman of The Mid Yorkshire Hospitals NHS Trust, said:
'This is wonderful news for everyone and we are delighted that our new hospitals
are now very much a reality. This development represents the single largest
investment in healthcare in the Wakefield district since the NHS was set up in
1948.
'Our patients will be able to experience first-class care, in first-class
facilities which have been carefully designed around the needs of patients,
visitors, carers and staff and will be modern, welcoming and accessible for
everyone.'
The concession company, Consort Healthcare (Mid Yorkshire), is a joint venture
between Balfour Beatty and the Royal Bank of Scotland. The construction work
will be carried out by Balfour Beatty Construction and Haden Young (the building
services arm of the Balfour Beatty Group). Facilities management for all estates
and facilities services (including catering, cleaning, portering, security,
linen and laundry) will be provided by Haden Building Management, another
Balfour Beatty subsidiary, under an arrangement that could yield over £400
million of long-term service revenue - the largest healthcare services contract
secured to date by the company.
It is expected that the new Pontefract Hospital will open in 2009 and that the
new Pinderfields Hospital will open in 2010, although some facilities will be
opened in advance of these dates.
Consort Healthcare is now the PPP concession company for nine major hospitals
and has a committed equity investment of £123 million in the sector.
ENDS
Enquiries to:
Tim Sharp
Tel: 020 7216 6884
www.balfourbeatty.com
Notes to Editors
----------------
1. Balfour Beatty is a leader in the UK PPP market with approximately £350
million committed investment in 24 operational projects and a further six
at preferred bidder stage.
2. Balfour Beatty's existing PPP hospital schemes are as follows:
- £90 million Durham Hospital (opened 2001)
- £220 million Edinburgh Royal Infirmary (opened 2003)
- £280 million University College London Hospital (Phase 1 opened 2005)
- £116 million Royal Blackburn Hospital (opened 2006)
- £553 million Birmingham New Hospitals (under construction; due to open
2011)
- £120 million Salford Hospital (preferred bidder)
- £60 million Tameside Hospital (preferred bidder)
- £152 million Fife Hospital (preferred bidder).
3. Balfour Beatty is the construction partner to Canmore Partnership Ltd in the
PPP concession for the new Victoria and Stobhill Hospitals in Glasgow. This
project, which began in August 2006, involves some £180 million of design
and construction work and is due for completion in spring 2009. In Glasgow,
Balfour Beatty is also building the new mental health secure unit at
Stobhill and the new Beatson Institute cancer research facility at Garscube.
4. Balfour Beatty is a world-class engineering, construction and services
group, well positioned in infrastructure markets which offer significant
growth potential. Its partnerships with public and private customers
generate secure, long-term income. Its financial position, with significant
net cash and with strong operating cash flows, offers continuing
flexibility to add additional capacity and expertise to the business mix
and to make appropriate investments in PPP/PFI and other long-term growth
opportunities.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.